Cash & equivalents increased 65.8%
Cash & equivalents changed +65.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +65.8% from the comparable as-filed period.
Gross margin changed -269 basis points from the comparable as-filed period.
Gross profit changed -22.1% from the comparable as-filed period.
Inventory changed +21.9% from the comparable as-filed period.
Net income changed +64.2% from the comparable as-filed period.
Operating income changed -47.2% from the comparable as-filed period.
Revenue changed -11.9% from the comparable as-filed period.
Selling, general & administrative changed -17.5% from the comparable as-filed period.
Operating margin changed -180 basis points from the comparable as-filed period.
Research & development changed +1.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.